Anticancer Res. 1999 Jan-Feb;19(1B):635-8.

Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).

Csatary LK, Moss RW, Beuth J, Töröcsik B, Szeberenyi J, Bakacs T.

Source

United Cancer Research Institute, Alexandria, VA, USA.

Abstract

Newcastle Disease Virus Vaccine (MTH-68/H) was administered to patients suffering from advanced neoplastic diseases after non-efficient tumor-destructive treatment. Case reports of selected patients suggest promising effects of this treatment. A prospectively-randomized clinical study (phase III; in accordance with Good Clinical Practice, GCP) was proposed to confirm these results and is currently under consideration.

PMID:: 10216468; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate. [Cancer Immunol Immunother. 2006]
Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate.
Salcedo M, Bercovici N, Taylor R, Vereecken P, Massicard S, Duriau D, Vernel-Pauillac F, Boyer A, Baron-Bodo V, Mallard E, et al. Cancer Immunol Immunother. 2006 Jul; 55(7):819-29. Epub 2005 Sep 27.
Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma. [Clin Cancer Res. 1996]
Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.
Ockert D, Schirrmacher V, Beck N, Stoelben E, Ahlert T, Flechtenmacher J, Hagmüller E, Buchcik R, Nagel M, Saeger HD. Clin Cancer Res. 1996 Jan; 2(1):21-8.
Dendritic-cell vaccination for metastatic melanoma? [Lancet Oncol. 2006]
Dendritic-cell vaccination for metastatic melanoma?
Chen V. Lancet Oncol. 2006 May; 7(5):368.
Review Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha. [Clin Cancer Res. 2002]
Review Active immunotherapy of metastatic melanoma with allogeneic melanoma lysates and interferon alpha.
Vaishampayan U, Abrams J, Darrah D, Jones V, Mitchell MS. Clin Cancer Res. 2002 Dec; 8(12):3696-701.
Review Vaccines for melanoma. [Dermatol Clin. 2002]
Review Vaccines for melanoma.
Bystryn JC. Dermatol Clin. 2002 Oct; 20(4):717-25.

See reviews... See all...

Cited by 4 PubMed Central articles

An overview on the development of newcastle disease virus as an anti-cancer therapy. [Malays J Med Sci. 2003]
An overview on the development of newcastle disease virus as an anti-cancer therapy.
Omar AR, Ideris A, Ali AM, Othman F, Yusoff K, Abdullah JM, Wali HS, Zawawi M, Meyyappan N. Malays J Med Sci. 2003 Jan; 10(1):4-12.
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. [J Virol. 2009]
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase.
Jarahian M, Watzl C, Fournier P, Arnold A, Djandji D, Zahedi S, Cerwenka A, Paschen A, Schirrmacher V, Momburg F. J Virol. 2009 Aug; 83(16):8108-21. Epub 2009 Jun 10.
Genetically engineered Newcastle disease virus for malignant melanoma therapy. [Gene Ther. 2009]
Genetically engineered Newcastle disease virus for malignant melanoma therapy.
Zamarin D, Vigil A, Kelly K, García-Sastre A, Fong Y. Gene Ther. 2009 Jun; 16(6):796-804. Epub 2009 Feb 26.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Beneficial treatment of patients with advanced cancer using a Newcastle disease ...
Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).
Anticancer Res. 1999 Jan-Feb ;19(1B):635-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Beneficial treatment of patients with advanced cancer using a Newcastle disease virus vaccine (MTH-68/H).

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information